Last updated: March 29, 2024
Sponsor: Parc Taulí Hospital Universitari
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sleep Disorders
Sleep Apnea Syndromes
Covid-19
Treatment
Influvac Tetra
Clinical Study ID
NCT06341374
2023/5079
Ages 18-70 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participants over 18 years old with diagnosis of COVID-19 during first year ofcoronavirus pandemic in March-June 2021.
Exclusion
Exclusion Criteria:
- >70 years and <18 years
- Recent COVID-19 (<6 months)
- Other infection (<3 months)
- Obstructive sleep apnea in treatment with CPAP prior to COVID infection.
- Immunosuppressed
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Influvac Tetra
Phase:
Study Start date:
November 06, 2023
Estimated Completion Date:
September 30, 2024
Study Description
Connect with a study center
Hospital Universitari Parc Tauli
Sabadell, Barcelona 08208
SpainActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.